Variant Bio

So fun to see a physical copy of our article that came out in Genome Research earlier this year! See the full open-access article here: https://lnkd.in/eUauYGs3

Olivia Gray, PhD from Variant Bio presenting at the Biology of Genomes conference this week about the important genomic resource that has resulted from one of our research collaborations in South Africa:

The importance of optimizing compounds’ design and determining the viability of drug candidates for use in humans: https://lnkd.in/gfTKxAmu

What does an ethics-first approach to genomic research and drug development look like? How can researchers do better? An interview with Sarah LeBaron von Baeyer, PhD -- cultural anthropologist and Director of Ethics & Engagement at Variant Bio.

We're honored to be a part of this important study -- the first-ever assessment of the burden of gout in French Polynesia: https://lnkd.in/ekJdWRaZ

Did you know, Variant Bio has had anthropologists on the team since Day 1? Sarah LeBaron von Baeyer, PhD, our Director of Ethics & Engagement, is giving a talk this week at NYU about her work:

In honor of Earth Day on April 22, biologist RC Chin-Wen Lai discusses the environmental impact of scientific innovation: https://lnkd.in/eBT5JTCe

Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments: https://lnkd.in/eqyCN_rp

Chemists S. Todd Meyer and Samantha Parker on Variant Bio’s R&D team are discovering new molecules to advance toward clinical development: https://lnkd.in/g53yJkZ5

What can companies like Variant Bio do to treat research participants and communities with respect? https://lnkd.in/eGCCiCrP